CARLSMED, INC. cotiza a 14.78 USD y tiene una capitalización bursátil de $404M. En los últimos 12 meses ha facturado $63M con un margen de flujo de caja libre del -58.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, us…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-0.39 | $-0.26 | $-0.29 |
| Estimado | $-0.38 | $-0.39 | $-0.39 | $-0.43 |
| Sorpresa | — | +0.0% | +33.3% | +32.6% |
| Métrica | CARL | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 75.3% | 57.0% | +18.3% |
| Operating Margin | -60.5% | -38.6% | -21.9% |
| Net Margin | -58.7% | -33.6% | -25.1% |
| FCF Margin | -58.6% | -13.9% | -44.8% |
| ROE | -30.0% | -40.4% | +10.4% |
| ROA | -22.8% | -32.0% | +9.2% |
| Current Ratio | 8.87 | 2.84 | +6.03 |
| Debt / Equity | 0.16 | 0.28 | -0.12 |